Recent Posts

FDA grants orphan drug designation for neuroblastoma vaccine

The U.S. Food and Drug Administration (FDA) granted orphan drug designation for a neuroblastoma vaccine from MabVax Therapeutics, providing development incentive with market exclusivity of the novel treatment for children with this deadly childhood cancer.

Read more here: http://www.news-medical.net/news/20141006/FDA-grants-orphan-drug-designation-for-neuroblastoma-vaccine.aspx

Archive
Search By Tags